SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jerzy Jaroszewicz, Robert Flisiak, Geoffrey Dusheiko, A pill for HCV – myth or foreseeable future?, Liver International, 2014, 34, 1
  2. 2
    David A. DeGoey, John T. Randolph, Dachun Liu, John Pratt, Charles Hutchins, Pamela Donner, A. Chris Krueger, Mark Matulenko, Sachin Patel, Christopher E. Motter, Lissa Nelson, Ryan Keddy, Michael Tufano, Daniel D. Caspi, Preethi Krishnan, Neeta Mistry, Gennadiy Koev, Thomas J. Reisch, Rubina Mondal, Tami Pilot-Matias, Yi Gao, David W. A. Beno, Clarence J. Maring, Akhter Molla, Emily Dumas, Andrew Campbell, Laura Williams, Christine Collins, Rolf Wagner, Warren M. Kati, Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A, Journal of Medicinal Chemistry, 2014, 57, 5, 2047

    CrossRef

  3. 3
    Jesús Ruiz Ramos, Irene Romero Hernández, Patricia Marrero Álvarez, María Remedios Marqués Miñana, María José Fernández Megía, José Luis Poveda Andrés, Experiencia en el manejo de inmunosupresores con los fármacos inhibidores de proteasa frente al virus de la hepatitis C, Gastroenterología y Hepatología, 2014,

    CrossRef

  4. 4
    S. Ciesek, M.P. Manns, K. Wursthorn, Aktueller Stand der Lebertransplantation, Der Gastroenterologe, 2013, 8, 1, 35

    CrossRef

  5. 5
    Susanne Beckebaum, Iyad Kabar, Vito R. Cicinnati, Hepatitis B and C in liver transplantation: new strategies to combat the enemies, Reviews in Medical Virology, 2013, 23, 3
  6. You have free access to this content6
    Asmeen Bhatt, Gregory T. Everson, Hepatitis C virus: Antiviral therapy in wait-listed patients, Clinical Liver Disease, 2013, 2, 4
  7. 7
    Ivo Graziadei, Lebertransplantation, Wiener klinische Wochenschrift Education, 2013, 8, 2, 43

    CrossRef

  8. 8
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Living-Donor Liver Transplantation and Hepatitis C, HPB Surgery, 2013, 2013, 1

    CrossRef

  9. 9
    Sung Won Lee, Si Hyun Bae, Management of Hepatitis C Viral Infection Pre- and Post-liver Transplantation, The Journal of the Korean Society for Transplantation, 2013, 27, 1, 1

    CrossRef

  10. 10
    James R. Burton, Gregory T. Everson, Management of the Transplant Recipient with Chronic Hepatitis C, Clinics in Liver Disease, 2013, 17, 1, 73

    CrossRef

  11. You have free access to this content11
    Tsunamasa Watanabe, Yasuhito Tanaka, Reactivation of hepatitis viruses following immunomodulating systemic chemotherapy, Hepatology Research, 2013, 43, 2
  12. 12
    P.S. Yoo, V. Umman, M.I. Rodriguez-Davalos, S.H. Emre, Retransplantation of the Liver: Review of Current Literature for Decision Making and Technical Considerations, Transplantation Proceedings, 2013, 45, 3, 854

    CrossRef

  13. 13
    Faisal M. Sanai, Dujana Mousa, Abdallah Al-Mdani, Ghada Al-Shoail, Hamad Al-Ashgar, Khalid Al Meshari, Ahmed Al-Qahtani, Mayssa Saadeh, Khalid I. Bzeizi, Hassan Aleid, Safety and efficacy of peginterferon-α2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C, Journal of Hepatology, 2013, 58, 6, 1096

    CrossRef

  14. 14
    Peter Ferenci, Sandra Beinhardt, Silibinin: An old drug in the high tech era of liver transplantation, Journal of Hepatology, 2013, 58, 3, 409

    CrossRef

  15. 15
    Gregory T. Everson, Asmeen Bhatt, Treatment of Hepatitis C in the Patient with Decompensated Cirrhosis, Current Hepatitis Reports, 2013, 12, 4, 236

    CrossRef

  16. You have free access to this content16
    Asmeen Bhatt, y Gregory T. Everson, Virus de la hepatitis C: Terapia antiviral en pacientes en la lista de espera, Clinical Liver Disease, 2013, 2, S5
  17. 17
    Syed-Mohammed Jafri, Stuart C. Gordon, Care of the Cirrhotic Patient, Infectious Disease Clinics of North America, 2012, 26, 4, 979

    CrossRef

  18. 18
    Tommaso Maria Manzia, Roberta Angelico, Luca Toti, Quirino Lai, Paolo Ciano, Mario Angelico, Giuseppe Tisone, Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation, Expert Review of Clinical Immunology, 2012, 8, 7, 635

    CrossRef

  19. 19
    Shahin Ghasemi, Ali Kabir, Mojtaba Ansari Jafari, Mohammad Jalali, Afshin Amini, Amir Hossein Faghihi-Kashani, Seyed Moayed Alavian, Psychometric Properties of a Standardized Questionnaire of Knowledge, Attitude, and Practice of Iranian Medical Specialists about Viral Hepatitis, Hepatitis Monthly, 2012, 12, 12

    CrossRef

  20. 20
    Christoph R. Werner, Daniel P. Egetemeyr, Ulrich M. Lauer, Silvio Nadalin, Alfred Königsrainer, Nisar P. Malek, Christoph P. Berg, Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: A 12-week pilot study providing safety and efficacy data, Liver Transplantation, 2012, 18, 12
  21. 21
    David Mutimer, Understanding the switchbacks: The impact of direct antivirals on the minimization of hepatitis C virus recurrence after transplantation, Liver Transplantation, 2012, 18, S2